Day Two – August 1, 2007 Day One - July 31, 2007       Day Three – August 2, 2007
Registration Desk Open     7:00am - 5:30pm     Ballroom Foyer
	CLICK THE ICONS BELOW TO WATCH THE REPLAY WEBCAST OF THIS ENTIRE PLENARY SESSION II REPLAY Click Here For Technical Support 8:00 - 8:10am     WELCOME Carol D. Linden, Ph.D. Principal Deputy Director and Acting Director, Office of Biomedical Advanced Research and Development Authority Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services 8:10 - 8:30am NATIONAL PANDEMIC INFLUENZA PLAN Kenneth Staley, M.D., M.P.A. Director for Public Health Policy, Homeland Security Council, Executive Office of the President 8:30 - 8:45am HHS PANDEMIC INFLUENZA IMPLEMENTATION PLAN - PROGRESS TO DATE ADM John O. Agwunobi, M.D., M.B.A., M.P.H. Assistant Secretary for Health, Department of Health and Human Services 8:45 - 9:00am NATIONAL VACCINE PROGRAM OFFICE'S PANDEMIC INFLUENZA PLAN IMPLEMENTATION ACTIVITIES Bruce Gellin, M.D., M.P.H. Director, National Vaccine Program Office, Department of Health and Human Services 9:00 - 9:15am U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF THE ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE IMPLEMENTATION ACTIVITIES Gerald W. Parker, D.V.M., Ph.D., M.S. Principal Deputy Assistant Secretary Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services 9:15 - 9:30am NATIONAL INSTITUTES OF HEALTH'S PANDEMIC INFLUENZA IMPLEMENTATION ACTIVITIES Roland A. Levandowski, M.D. Chief, Influenza, SARS and Other Viral Respiratory Diseases Section, Respiratory Diseases Branch Division of Microbiology and Infectious Diseases, National Institutes of Health, Department of Health and Human Services 9:30 - 9:45am CENTERS FOR DISEASE CONTROL AND PREVENTION'S PANDEMIC INFLUENZA PLAN IMPLEMENTATION ACTIVITIES CAPT Stephen Redd, M.D. Influenza Team Lead, Coordinating Center for Infectious Diseases Centers for Disease Control and Prevention, Department of Health and Human Services 9:45 - 10:00am FOOD AND DRUG ADMINISTRATION'S PANDEMIC INFLUENZA PLAN IMPLEMENTATION ACTIVITIES Mark Goldberger, M.D., M.P.H. Medical Director for Emerging and Pandemic Threat Preparedness, Center for Biologics Evaluation and Research Food and Drug Administration, Department of Health and Human Services 10:00 - 10:15am DEPARTMENT OF DEFENSE PANDEMIC INFLUENZA ACTIVITIES LTC Wayne E. Hachey, D.O., M.P.H. Director Preventive Medicine, Office of the Assistant Secretary of Defense (Health Affairs) Force Health Protection and Readiness, Department of Defense
BREAK     10:15 - 10:35AM     Ballroom Foyer
	CLICK THE ICONS BELOW TO WATCH THE REPLAY WEBCAST OF THIS ENTIRE PANEL SESSION II REPLAY Click Here For Technical Support 10:35 - 11:15am     PANDEMIC INFLUENZA ANTIVIRAL DRUG STOCKPILE PARTNERING PANEL Moderator: Arthur Y. Elliot, M.D., Ph.D. Senior Program Manager, Antivirals, Pandemic Influenza Preparedness Office of Biomedical Advanced Research and Development Authority Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services Dominick Iacuzio, Ph.D. Medical Director, Hoffman-La Roche, Inc. Adam Kesselman Relenza Global Product Director, GlaxoSmithKline Susan C. Penfield, M.D. Manager, Infectious Disease Control Unit, Texas State Department of Health Stephen S. Morse, Ph.D., F.A.A.M., F.A.C.E. Founding Director & Senior Research Scientist, Center for Public Health Preparedness National Center for Disaster Preparedness; Assoc. Professor, Columbia University, Mailman School of Public Health 11:20 - 12:00pm PANDEMIC INFLUENZA MEDICAL COUNTERMEASURE RESEARCH AND DEVELOPMENT PANEL Moderator: Benjamin Schwartz, M.D. Senior Science Advisor, National Vaccine Program Office, Department of Health and Human Services Daniel R. Perez, Ph.D Assistant Professor, Virginia - Maryland Regional College of Veterinary Medicine University of Maryland, College Park David Spiro, Ph.D. Assistant Investigator, Viral Genomics, J. Craig Venter Institute Richard J. Whitley, M.D. Professor of Pediatric Infectious Diseases, University of Alabama School of Medicine
LUNCH ON YOUR OWN     12:00PM - 1:30
	CLICK THE ICONS BELOW TO WATCH THE REPLAY WEBCAST OF THIS ENTIRE PLENARY SESSION III REPLAY Click Here For Technical Support 1:30 - 1:50pm     CHEMICAL, BIOLOGICAL, RADIOLOGICAL, AND NUCLEAR THREAT ASSESSMENTS John Vitko, Ph.D. Director of Biological and Chemical Countermeasures, Science and Technology Directorate Department of Homeland Security 1:50 - 2:10pm MEDICAL AND PUBLIC HEALTH CONSEQUENCE MODELING: CBRN THREATS AND PANDEMIC INFLUENZA Peter Highnam, Ph.D. Office of Biomedical Advanced Research and Development Authority Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services 2:10 - 2:30pm USING MODELING FOR MEDICAL COUNTERMEASURE GAP ANALYSIS: THE PANDEMIC INFLUENZA EXAMPLE CAPT Ann Knebel, R.N., D.N.Sc., F.A.A.N. Deputy Director for Preparedness Planning, Office of Preparedness and Emergency Operations Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services 2:30 - 2:50pm SURVEILLANCE AND SITUATIONAL AWARENESS Pamela S. Diaz, M.D. Senior Medical Advisor, Division of Bioterrorism Preparedness and Response Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention Department of Health and Human Services 2:50 - 3:00pm Q AND A
BREAK     3:00 - 3:20     Ballroom Foyer
	CLICK THE ICONS BELOW TO WATCH THE REPLAY WEBCAST OF THIS ENTIRE SEMINAR SESSION II & THE NEXT SEMINAR SESSION III REPLAY Click Here For Technical Support 3:20 - 3:50pm     ROLES IN SELECT AGENT USE: U.S. DEPARTMENT OF AGRICULTURE AND CENTERS FOR DISEASE CONTROL AND PREVENTION Lee Ann Thomas, D.V.M., M.S. Director, Animals, Organisms, Vectors and Select Agents National Center for Import and Export, U.S. Department of Agriculture Rob Weyant, Ph.D. Director of the Division of Select Agents and Toxins Coordinating Office for Terrorism, Preparedness and Emergency Response Centers for Disease Control and Prevention, Department of Health and Human Services 3:50 - 4:05pm NATIONAL INSTITUTES OF HEALTH - SUPPORTING INVESTIGATOR RESEARCH WITH SELECT AGENTS Paula Strickland, Ph.D. Director, Office of International Extramural Activities, National Institute of Allergy and Infectious Disease National Institutes of Health, Department of Health and Human Services 4:05 - 4:20pm Q AND A
	CLICK THE ICONS BELOW TO WATCH THE REPLAY WEBCAST OF THE PREVIOUS SEMINAR SESSION II & THIS SEMINAR SESSION III REPLAY Click Here For Technical Support 4:20 - 4:40pm     FOOD AND DRUG ADMINISTRATION'S (FDA) ROLE IN MEDICAL COUNTERMEASURE DEVELOPMENT RADM Boris Lushniak, M.D., M.P.H. Assistant Commissioner, Office of Counterterrorism Policy and Planning Food and Drug Administration, Department of Health and Human Services 4:40 - 5:30pm Q&A WITH THE FDA Cynthia L. Kelley, M.S. Senior Advisor for Counterterrorism/Medical Countermeasures Center for Biologics Evaluation and Research, Food and Drug Administration Department of Health and Human Services Rosemary Roberts, M.D. Director, Office of Counter-Terrorism and Emergency Coordination Center for Drug Evaluation and Research, Food and Drug Administration Department of Health and Human Services Steven Gutman, M.D., M.B.A. Director, Office of In Vitro Diagnostic Device Evaluation and Patient Safety Center for Devices and Radiological Health, Food and Drug Administration Department of Health and Human Services
back to top